English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2375]
News [3440]
Articles [281]
Editorials [30]
Conferences [171]
elearning [101]
Developing new radiotracers
Dr Stephen Paisey - Pre-Clinical Facilities Manager, PETIC, Cardiff, Wales
Developing new radiotracers ( Dr Stephen Paisey - Pre-Clinical Facilities Manager, PETIC, Cardiff, Wales )
20 Sep 2017
The difficulties of working with radiotracers
Dr Stephen Paisey - Pre-Clinical Facilities Manager, PETIC, Cardiff, Wales
The difficulties of working with radiotracers ( Dr Stephen Paisey - Pre-Clinical Facilities Manager, PETIC, Cardiff, Wales )
14 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (2/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
Pembrolizumab falls short of endpoints in KEYNOTE 40
Dr Ezra Cohen - UC San Diego Health, San Diego, USA
Pembrolizumab falls short of endpoints in KEYNOTE 40 ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )
11 Sep 2017
ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients
Prof Jonathan Ledermann - University College London Hospitals, London, UK
ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients ( Prof Jonathan Ledermann - University College London Hospitals, London, UK )
11 Sep 2017
Patient empowerment and quality of life
Prof Françoise Meunier - Director General of EORTC, Brussels, Belgium
Patient empowerment and quality of life ( Prof Françoise Meunier - Director General of EORTC, Brussels, Belgium )
11 Sep 2017
Chemoradiation remains best treatment for locally advanced cervical cancer
Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India
Chemoradiation remains best treatment for locally advanced cervical cancer ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )
11 Sep 2017
Fertility-preserving procedures in BRCA mutation-positive breast cancer
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Fertility-preserving procedures in BRCA mutation-positive breast cancer ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
11 Sep 2017
Biological insight in new drug combinations
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biological insight in new drug combinations ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017
BRIM8: Vemurafenib in high risk melanoma patients
Dr Karl Lewis - University of Colorado Denver, Colorado, USA
BRIM8: Vemurafenib in high risk melanoma patients ( Dr Karl Lewis - University of Colorado Denver, Colorado, USA )
11 Sep 2017
Durvalumab in novel combinations for head and neck cancer
Dr Ezra Cohen - UC San Diego Health, San Diego, USA
Durvalumab in novel combinations for head and neck cancer ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )
11 Sep 2017
<1...162163164165166...198>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top